A B the arterial and venous phase. On the late phase however a nearly homogenous uptake in the lesions was demonstrated (Fig. 2) .
The patient was scheduled for CTguided biopsy. The tentative histopathological diagnosis was leiomyoma, but malignant leiomyosarcoma could not be ruled out on basis of the biopsy. The tumor markers showed normal levels of B-HCG, CEA and CA125 and on the PET-examination no tracer uptake was shown for the nodules. These results practically excluded malignancy. The patient was scheduled for a MRI of the abdomen. The nodules showed an intensity similar to smooth muscle (Fig. 3) .
On explorative laparatomy surgical specimens were taken for a more definite PA diagnosis. The PA report described no sign of necrosis, norbeen suggested to be associated with distant urogenital leimyomas. The time interval between hysterectomy and metastases can reach up to 20 years.
Although the clinical presentation is nonspecific, symptoms such as chest pain, abdominal discomfort and dyspnea have been described.
Usually these tumors arise in the genitourinary tract but may arise in or metastasize to nearly any anatomic site. In case of invasion of the peritoneal cavity the condition is called leiomyomatosis peritonealis disseminata or diffuse peritoneal leiomyomatosis (4). The exact pathophysiology of disseminated leiomyomatosis remains enigmatic. Local overgrowth of smooth muscle cells under hormonal influence has been hypothesized (5). Intra-abdominal deposition during surgery for a primal mitotic activity and no nuclear polymorphism, confirming the diagnosis of diffuse peritoneal leiomyomatosis.
Discussion
Leiomyomas of the urogenital tract are primarily benign disorders and reports on metastases from these tumors are infrequently encountered in the literature. These benign tumors of smooth muscle origin are more common in the urogenital tract while leiomyomatosis in unusual locations can pose a diagnostic challenge. Women in their reproductive age or using oral contraceptives are at risk for developing leiomyomas outside the urogenital tract. A hormonal influence has therefore been hypothesized (3). History of hysterectomy has also A B C D mary urogenital leiomyoma is another hypothesis (6) . Although a highly malignant leiomyosarcoma can be readily diagnosed histopathologically, the distinction between a leiomyoma and a low-grade leiomyosarcoma can be challenging. The latter entity must be ruled out regarding the evident clinical implications. Laparatomy and surgical biopsy are essential for a definitive diagnosis.
In this paper we have reported a case of leiomyomatosis of the abdominopelvic cavity, first described in 1965 (3). This entity strongly mimics peritoneal metastasis. Knowledge of the imaging characteristics of this benign entity, therefore helps the radiologist to recognise this disorder, with peritoneal carcinomatosis being the most important differential diagnosis. Lymphoma, tuberculosis and mesothelioma are also other potential mimickers. Ultrasound characteroophorectomy leads to a good overall prognosis and survival rate.
Conclusion
Leiomyomatosis peritonealis disseminata is a very rare benign disorder affecting middle aged women. The differentiation from leiomyosarcoma is essential and requires imaging and histopathological workup. Knowledge of the main features is important for the radiologist in order to correctly diagnose this entity and prevent unnecessary and potentially harmful intervention.
istics include homogenous hypoechoic, solid nodules with low to moderate vascularity (7) . Contrast enhanced CT will reveal solid lesions dispersed in the abdominal cavity with heterogeneous contrast uptake in the arterial and venous phase, gradually progressing to a homogenous uptake in the late phase (8) . Iso-intensity with skeletal muscle on T1 and T2 is the most important MRI feature. Administration of gadolinium reveals homogenous enhancement of the lesions in the late phase (9) .
On positron emission tomography (PET) the nodules show no uptake of FDG, whereas malignant lesions classically show avid FDG uptake. PET is therefore a key modality for the differentiation of LPD from malignant peritoneal disease.
The treatment of LPD is generally surgical. Resection of the primary tumors, metastatic implants and Fig. 3. -MRI of the abdomen shows iso-intensity of the lesions with skeletal muscle (A). After Gadolinium injection there is heterogeneous enhancement in the early phase (B, 30 sec), gradually progressing to homogenous enhancement on the late phase (C, 90 sec).
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